公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer | Chen J.S.; CHIH-HUNG HSU ; Chiang N.J.; Tsai C.S.; Tsou H.H.; Huang S.F.; Bai L.Y.; Chang I.C.; Shiah H.S.; Ho C.L.; Yen C.J.; Lee K.D.; Chiu C.F.; Rau K.M.; Yu M.S.; Yang Y.; Hsieh R.K.; Chang J.Y.; Shan Y.S.; Chao Y.; Chen L.-T.; Chin Y.-H.; Chung T.-R.; Yu W.-L.; Lee M.-H.; Lin L.-F.; Lin P.-C.; Wu Y.-L.; Wang H.-L.; Lu L.-J.; Chen S.-Y.; Wu C.-C.; Wei T.-C.; on behalf of the Taiwan Cooperative Oncology Group | Annals of Oncology | 131 | 115 | |
2006 | An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer | Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH ; Kao W.Y.; Chen L.T.; ANN-LII CHENG | British Journal of Cancer | 13 | 13 | |
2013 | Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial | Azim H.A.; Agbor-Tarh D.; Bradbury I.; Dinh P.; Baselga J.; Di Cosimo S.; Greger Jr. J.G.; Smith I.; Jackisch C.; Kim S.-B.; Aktas B.; CHIUN-SHENG HUANG ; Vuylsteke P.; Hsieh R.K.; Dreosti L.; Eidtmann H.; Piccart M.; De Azambuja E. | Journal of Clinical Oncology | 48 | 47 | |
2004 | Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer | Chao Y.; KUN-HUEI YEH ; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG | British Journal of Cancer | 72 | 63 | |
2008 | A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline | RUEY-LONG HONG ; CHING-HUNG LIN ; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. | Cancer Chemotherapy and Pharmacology | 9 | 7 | |
1990 | Remission induction of ANLL with low dose cytosine arabinoside combined with retinoic acid. | Chen P.M.; Hsieh R.K.; Chuang M.W.; Liu J.H.; Fan S.; CHUN-JEN LIU ; Tzeng C.H. | Zhonghua yi xue za zhi = Chinese medical journal; Free China ed | 0 | 0 |